Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis

Background: Recalcitrant neovascular age-related macular degeneration (rnAMD) despite intensive intravitreal anti-neovascular endothelial growth factor (VEGF) treatment, can be handled by switching to another anti-VEGF agent. This first systematic review and meta-analysis presents long-term data aft...

Descrición completa

Detalles Bibliográficos

Principais autores:	Christof Hänsli, Christin Schild, Isabel Pfister, Justus G. Garweg
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2023-03-01
Series:	Life
Assuntos:	neovascular age-related macular degeneration brolucizumab switch meta-analysis anti-VEGF recalcitrant nAMD
Acceso en liña:	https://www.mdpi.com/2075-1729/13/3/814
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!